Here are relevant reports on : global-live-streaming-industry
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at USD3.84 billion in 2025, stood at USD4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of USD5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at USD4.39 billion in 2025, stood at USD4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Metaverse in Entertainment Market by Offering (Hardware, Software, Professional Services), Technology (XR, AI, Blockchain, Cloud & Edge), Entertainment Type (Gaming, Live Events, Sports, Music, Films & TV), and Region - Global Forecast to 2032
The global metaverse in entertainment market size will grow to USD 121.96 billion by 2032 from USD 30.6 billion in 2026, at a CAGR of 25.9% during the forecast period. Some of the key players operating in the metaverse in entertainment market are Roblox (US), Epic Games (US), Meta (US), Microsoft (US), Take-Two Interactive (US), Electronic Arts (US), Apple (US), Sony Group Corporation (Japan), Google (US), Unity Technologies (US), Deloitte (UK), Tata Consultancy Services (TCS) (India), DPVR (China), Capgemini (France), Pimax (China), Rokid (China), Magic Leap (US), Tencent (China), NetEase (China), Valve (US), HTC Corporation (Taiwan), TCL (China), Samsung Electronics (South Korea), ByteDance (China), XREAL (China), Decentraland (Argentina), Niantic (US), VRChat (US), The Sandbox (Hong Kong), Uplandme, Inc. (US), and Play For Dream (China).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cloud Gaming Market Size, Share and Industry Growth Analysis Report by Offering (Infrastructure, Gaming Platform Services), Device Type (Smartphones, Tablets, Gaming Consoles, PCs & Laptops, Smart TVs, HMDs), Solution (Video Streaming, File Streaming), Gamer Type, Region 2024-2031
The global cloud gaming market was valued at USD 3.34 billion in 2024 and is estimated to reach USD 40.20 billion by 2031, at a CAGR of 41.1% between 2025 and 2031. The major players in the cloud gaming market are NVIDIA (US), Intel (US), Google (US), Microsoft (US), Amazon (US), Advanced Micro Devices (US), Sony (Japan), IBM (US), Tencent (China), and Alibaba (China).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Wi-Fi 7 Market by Hardware (Access Point, Router, System on Chip), by Location Type (Indoor, Outdoor), by Applications (Immersive Technologies, HD Video Streaming, Smart Devices, Industry 4.0, Telemedicine, Public Wi-Fi & Dense Environments), by Solution (Access Point, Router, System on Chip) - Global Forecast to 2030
The Wi-Fi 7 market is projected to reach USD 24.2 billion by 2030, at a CAGR of 57.2% during the forecast period. The major vendors covered in the Wi-Fi 7 market Qualcomm (US), Broadcom (US), TP-Link (China), ZTE (China), Mediatek (Taiwan), Keysight Technologies (US), MaxLinear (US), Huawei (China), Commscope (US), Vantiva (France), LitePoint (US), Rohde & Schwarz (Germany), Intel (US), HFCL (India), Netgear (US), SDMC Technology (China), Senscomm Semiconductor (China), H3C (China), VVDN Technologies (India), Actiontec Electronics (US), ADB Global (Switzerland), Ruijie Networks (China), and Edgewater Wireless Systems (Canada).
- Published: June 2023
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
